We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
MADOPAR 62.5 levodopa 50 mg and benserazide 12.5 mg capsule bottle, Roche Products Pty Ltd, CON-1265
Product name
MADOPAR 62.5 levodopa 50 mg and benserazide 12.5 mg capsule bottle
Sponsor name
Roche Products Pty Ltd
Consent start
Consent no.
CON-1265
Duration
The consent is effective from 26 August 2024 until 31 August 2025.
Standard
Paragraph 6(1)(a) of Therapeutic Goods Order No. 95 - Child-resistant packaging requirements for medicines 2017 (TGO 95)
Non-compliance with standard
The products are not contained within child-resistant packaging.
Conditions imposed
The sponsor will continue to monitor for any incidents where a child accesses
the medicine inappropriately and report all such incidents to the Therapeutic
Goods Administration.
Import, Supply, &/or Export
import and supply
Therapeutic product type
Prescription medicines